BioInvenu Inc. produces comprehensive GPCR beta-arrestin assay products, and will develop novel nuclear hormone receptor (NHR), receptor tyrosine kina

BioInvenu���s proprietary LinkLight��� technology offers innovative tools for cell based protein-protein interaction assays. LinkLight��� technology provides simple, robust, economic, and sensitive methods to detect molecules modulating protein-protein interactions in whole cells with immediate and stable signals. LinkLight��� technology does not involve transcription and translation signal cascade, therefore reducing false and off-target signals. Unlike enzyme fragment complementation as...

BioInvenu���s proprietary LinkLight��� technology offers innovative tools for cell based protein-protein interaction assays. LinkLight��� technology provides simple, robust, economic, and sensitive methods to detect molecules modulating protein-protein interactions in whole cells with immediate and stable signals. LinkLight��� technology does not involve transcription and translation signal cascade, therefore reducing false and off-target signals. Unlike enzyme fragment complementation assays, LinkLight��� assays generate stable signals even for rapid transient protein-protein interactions, and avoid high background signals due to enzyme fragment self complementation. LinkLight��� technology provides an assay platform to study target-specific and signaling pathway-specific signal readout in wh